Abstract

Selenium has been intensively studied for the use of cancer prevention and treatment. However, the clinical effects are still plausible. To enhance its efficacy, a combinational study of selenium yeast (SY) and fish oil (FO) was performed in A549, CL1-0, H1299, HCC827 lung adenocarcinoma (LADC) cells to investigate the enhancement in apoptosis induction and underlying mechanism. By sulforhodamine B staining, Western blot and flow cytometric assays, we found a synergism between SY and FO in growth inhibition and apoptosis induction of LADC cells. In contrast, the fetal lung fibroblast cells (MRC-5) were unsusceptible to this combination effect. FO synergized SY-induced apoptosis of A549 cells, accompanied with synergistic activation of AMP-activated protein kinase (AMPK) and reduction of Cyclooxygenase (COX)-2 and β-catenin. Particularly, combining with FO not only enhanced the SY-elevated proapoptotic endoplasmic reticulum (ER) stress marker CCAAT/enhancer-binding protein homologous protein (CHOP), but also reduced the cytoprotective glucose regulated protein of molecular weight 78 kDa (GRP78). Consequently, the CHOP downstream targets such as phospho-JNK and death receptor 5 were also elevated, along with the cleavage of caspase-8, -3, and the ER stress-related caspase-4. Accordingly, inhibition of AMPK by compound C diminished the synergistic apoptosis induction, and elevated CHOP/GRP78 ratio by SY combined with FO. The AMPK-dependent synergism suggests the combination of SY and FO for chemoprevention and integrative treatment of LADC.

Highlights

  • Lung cancer is the leading cause of cancer-related mortality worldwide, and its rate of incidence continues increasing [1]

  • It had been reported that 500 ng/mL was the upper limit of the mean plasma selenium levels associated with toxicity in human [28]

  • As apoptosis induction through endoplasmic reticulum (ER) stress cascade is crucial for the anticancer activity of selenium [8,15], dietary nutraceutical with complementary mechanism of action in modulating the cascade is engaging for this purpose

Read more

Summary

Introduction

Lung cancer is the leading cause of cancer-related mortality worldwide, and its rate of incidence continues increasing [1]. Selenium compounds have been intensively studied, in many experimental models, against several malignancies, including lung cancer [3]. A variety of clinical trials were conducted to evaluate the safety and efficacy of selenium in lung cancers patients [5,6]. A recent study of meta-analysis and meta-regression concluded that high selenium exposure decreased the risk of lung cancer, as well as other four types of cancers (breast, esophageal, gastric and prostate) [6], some outcomes of other trials were not as favorable as expected or even conflict [5,7]. As the potency of a single dietary component might be limited, further combinational study was prompted to enhance the efficacy of selenium for the prevention and treatment of lung cancer

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call